Evidence mapPaperPMID 36367601Full record

Observational studyInternational journal of clinical pharmacy2023

Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic.

C Cheng, A Walsh, S Jones, S Matthews, D Weerasooriya, R J Fernandes, C A McKenzie

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in International journal of clinical pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Thank you from the Editor-in-Chief.International journal of clinical pharmacy · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

C ChengPharmacy Department, Kings College Hospital, London, SE5 9RS, UK. caroline.cheng@nhs.net.ORCID http://orcid.org/0000-0003-1545-7612
A WalshPharmacy Department, Kings College Hospital, London, SE5 9RS, UK.
S JonesPharmacy Department, Kings College Hospital, London, SE5 9RS, UK.
S MatthewsPharmacy Department, Medway NHS Foundation Trust, Gillingham, ME7 5NY, UK.
D WeerasooriyaPharmacy Department, Kings College Hospital, London, SE5 9RS, UK.
R J FernandesPharmacy Department, Kings College Hospital, London, SE5 9RS, UK.
C A McKenziePharmacy Department, Kings College Hospital, London, SE5 9RS, UK.
King's College Hospital · GBKing's College London · GBKing's College - North Carolina · USMedway NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls.

aimTo optimise medicines seven-days a week during surge-2 of the COVID-19 pandemic through implementation of a seven-day clinical pharmacy service. This paper describes service development, evaluation and sustainability.

settingA tertiary-referral teaching hospital, London, United Kingdom. DEVELOPMENT: The seven-day clinical pharmacy service was developed to critical care, acute and general medical patients. Clinical leads developed the service specification and defined priorities, targeting complex patients and transfer of care. Contributing staff were briefed and training materials developed. IMPLEMENTATION: The service was implemented in January 2021 for 11 weeks. Multidisciplinary team communication brought challenges; strategies were employed to overcome these. EVALUATION: A prospective observational study was conducted in intervention wards over two weekends in February 2021. 1584 beds were occupied and 602 patients included. 346 interventions were reported and rated; 85.6% had high or moderate impact; 56.7% were time-critical. The proportion of medicines reconciliation within 24-h of admission was analysed across the hospital between November 2020 and May 2021. During implementation, patients admitted Friday-Sunday were more likely to receive medicines reconciliation within 24-h (RR 1.41 (95% CI 1.34-1.47), p < 0.001). Rostered services were delivered sustainably in terms of shift-fill rate and medicines reconciliation outcome.

conclusionSeven-day clinical pharmacy services benefit patient outcome through early medicines reconciliation and intervention. Investment to permanently embed the service was sustained.

Indexed as

COVID-19Pharmacy Service, HospitalHospitals, TeachingHumansMedication ReconciliationPandemicsPharmacistsReferral and ConsultationState MedicineTertiary Care CentersHospital pharmacy serviceHospitalsImplementation scienceMedication reconciliationPandemicsPharmacists

Identifiers

PMID36367601
PMCPMC9650667
OpenAlexW4308770079

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.